CHARACTERISTICS AND COMORBIDITIES INFLUENCING MORTALITY RISK AMONG PATIENTS WITH HEREDITARY ANGIOEDEMA
Author(s)
Subhan Khalid, PhD Candidate;
Harrisburg University, Data Science, Harrisburg, PA, USA
Harrisburg University, Data Science, Harrisburg, PA, USA
OBJECTIVES: Patients suffering from hereditary angioedema (HA) face a heightened mortality risk due to multiple factors. The purpose of this study was to identify patient demographics or comorbidities associated with higher mortality risk using Bayesian network (BN) analysis.
METHODS: Data from the 2021 Nationwide Inpatient Sample were used to identify hospitalized patients with hereditary angioedema. Patient demographics, comorbidities, and severity measures were analyzed, and a Bayesian network model was developed to assess factors contributing to mortality risk. Structure learning was performed using a directed acyclic graph and probability estimating using Bayesian Inference. Model performance was validated using a 70/30 training-testing split and assessed via area under the curve.
RESULTS: Older HA patients and those with autoimmune conditions, hypertension, or low income were at higher risk of mortality. Elevated risk was also observed across certain racial groups, insurance types, and income levels. Notably, older Black patients from the Midwest exhibited the highest estimated mortality risk. The Bayesian Network demonstrated strong predictive performance, highlighting its potential for identifying high-risk subgroups and supporting targeted clinical interventions.
CONCLUSIONS: The findings of this study provide valuable insights into the factors influencing mortality risk for HA patients, with BN analysis offering a detailed understanding of complex dependencies among patient demographics and comorbidities. These results have ramifications for both patients and physicians to improve HA symptom management and preventing onset of life-threatening situations.
METHODS: Data from the 2021 Nationwide Inpatient Sample were used to identify hospitalized patients with hereditary angioedema. Patient demographics, comorbidities, and severity measures were analyzed, and a Bayesian network model was developed to assess factors contributing to mortality risk. Structure learning was performed using a directed acyclic graph and probability estimating using Bayesian Inference. Model performance was validated using a 70/30 training-testing split and assessed via area under the curve.
RESULTS: Older HA patients and those with autoimmune conditions, hypertension, or low income were at higher risk of mortality. Elevated risk was also observed across certain racial groups, insurance types, and income levels. Notably, older Black patients from the Midwest exhibited the highest estimated mortality risk. The Bayesian Network demonstrated strong predictive performance, highlighting its potential for identifying high-risk subgroups and supporting targeted clinical interventions.
CONCLUSIONS: The findings of this study provide valuable insights into the factors influencing mortality risk for HA patients, with BN analysis offering a detailed understanding of complex dependencies among patient demographics and comorbidities. These results have ramifications for both patients and physicians to improve HA symptom management and preventing onset of life-threatening situations.
Conference/Value in Health Info
2026-05, ISPOR 2026, Philadelphia, PA, USA
Value in Health, Volume 29, Issue S6
Code
MSR122
Topic
Methodological & Statistical Research
Topic Subcategory
Artificial Intelligence, Machine Learning, Predictive Analytics
Disease
No Additional Disease & Conditions/Specialized Treatment Areas, SDC: Rare & Orphan Diseases